株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界の動物用抗感染薬市場:動物疾患、技術、動物、地域別 - 動向および予測

Global Veterinary Anti-infectives market Segmented by Veterinary disease types, by animal types & By Geography - Trends & Forecasts 2016-2021

発行 Mordor Intelligence LLP 商品コード 319398
出版日 ページ情報 英文 190 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.27円で換算しております。
Back to Top
世界の動物用抗感染薬市場:動物疾患、技術、動物、地域別 - 動向および予測 Global Veterinary Anti-infectives market Segmented by Veterinary disease types, by animal types & By Geography - Trends & Forecasts 2016-2021
出版日: 2016年08月01日 ページ情報: 英文 190 Pages
概要

世界の動物用抗感染薬市場は2014年に43億7,000万米ドルとなる見込みです。同市場は今後もCAGR8.5%で拡大し、2019年には69億2,000万米ドルに達するとみられています。動物の感染症の症例増加に対応するため、動物用抗感染薬市場は着実に成長を遂げています。

当レポートでは、世界の動物用抗感染薬市場の動向と将来予測、市場に参入する主要企業の競合環境、市場シェア、近年の動向とともにプロファイルをまとめています。

第1章 イントロダクション

第2章 市場分析

  • 動物医療製品市場
  • 動物医療とヒトの医療

第3章 市場動向

  • 市場促進因子
    • ペット所有率の上昇
    • 栄養の改善
    • 食品安全に対する消費者の意識向上
    • 家畜生産の増大
    • 人畜共通感染症、食品媒介疾患
  • 市場阻害因子
    • 耕作地と水の不足
    • 耕地に関する競争激化
    • 費用対効果の高い生産
  • ポーターズファイブフォース分析

第4章 世界の動物用抗感染薬市場セグメンテーション

  • 世界の動物用抗感染薬市場:疾患別
  • 世界の動物用抗感染薬市場:種類別
    • コンパニオンアニマル
    • 家畜
  • 世界の動物用抗感染薬市場:地域別
    • 北米
    • 欧州
    • アジア太平洋地域

第5章 競合環境

  • 市場における主要参入企業
  • 合併・買収
  • 新製品上市
  • 協定、連携、提携

第6章 企業プロファイル

  • Zoetis animal healthcare
  • Merck
  • Merial (Animal Health Division Of Sanofi)
  • Elanco
  • Bayer healthcare
  • Novartis Animal Health, Inc.
  • Virbac
  • Boehringer Ingelheim

第7章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

The global market for veterinary anti-infectives is estimated to be worth USD 4,298 million in 2014. Expected to grow at a healthy CAGR of 6.35%, the market is set to reach USD 6,218 million by 2020. Global veterinary healthcare offers services and products in various segments such as vaccines, parasiticides, anti-infectives, medicinal feed additives, other pharmaceuticals, out of which anti-infectives are growing at a steady pace to combat the increasing number of infectious diseases in animals. It is the second best segment after vaccines and holds about 20% of the global animal healthcare market share.

Global Veterinary Anti-Infectives Market- Market Dynamics

The report studies various driving and restraining factors for the global veterinary anti-infectives market. Some of these are listed below.

Drivers

  • Increase in pet ownership
  • Improved nutrition
  • Increasing zoonotic and foodborne diseases

Restraints

Increased competition for cultivated land and cost-effective production are the major obstacles in the path of global veterinary anti-infectives market.

The report highlights the segment-wise contribution of different anti-incentives by disease, species, and geography. By type of products, the market has been segmented into marbofloxacin, florfenicol, freeze-dried ceftiofur, beta-lactams, oxytetracycline, and aminosidine; by species into companion and farm animals and by geography into North America, Asia-Pacific, Europe and Rest of World.

Some of the key players in the market are:

  • Bayer Healthcare
  • Boehringer Ingelheim
  • Ceva Animal Health, Inc.
  • Elanco
  • Merck
  • Merial (Animal Health Division of Sanofi)

What the Report Offers

  • Market definition for the specified topic along with identification of key drivers and restraints for the market.
  • Market analysis for the veterinary anti-infectives market, with region-specific assessments and competition analysis on a global and regional scale.
  • Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.
  • Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.
  • Identification and analysis of the macro and micro factors that affect the veterinary anti-infectives market on both global and regional scale.
  • A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

Table of Contents

1. INTRODUCTION

  • 1.1. Market Definition
  • 1.2. Market Recent Trends

2.Market Analysis

  • 2.1. Market Animal Health Products
  • 2.2. Animal medicines vs. human Medicines

3.Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Increase in pet ownership
    • 3.1.2. Improved Nutrition
    • 3.1.3. Intensifying consumer focus on food safety
    • 3.1.4. Greater Livestock production
    • 3.1.5. Increasing Zoonotic and Foodborne Diseases
  • 3.2. Market Constraints
    • 3.2.1. Scarcity of arable land and water
    • 3.2.2. Increased competition for cultivated land
    • 3.2.3. Cost effective production
  • 3.3. Porter's Five Force Analysis
    • 3.3.1. Threat of New Entrant
    • 3.3.2. Internal Rivalry
    • 3.3.3. Buyer bargaining power
    • 3.3.4. Supplier bargaining power
    • 3.3.5. Threat of substitutes

4.Global Veterinary Anti-Infective Market Segmentation

  • 4.1. Global Veterinary Anti-infectives Market, By disease
    • 4.1.1. Marbofloxacin
    • 4.1.2. Florfenicol
    • 4.1.3. Freeze-dried ceftiofur
    • 4.1.4. Beta-lactams
    • 4.1.5. Oxytetracycline
    • 4.1.6. Aminosidine
  • 4.2. Global Veterinary Anti-Infectives Market, By species
    • 4.2.1. Companion Animals
      • 4.2.1.1Dogs
      • 4.2.1.2. Cats
      • 4.2.1.2. Horses
    • 4.2.2. Farm animal
      • 4.2.2.1. Cattle
      • 4.2.2.2. Swine
      • 4.2.2.3. Poultry
      • 4.2.2.4. Fish
      • 4.2.2.5. Sheep
  • 4.3. Global Veterinary Anti-Infectives Market Segmentation, By Geography
    • 4.3.1. North America
      • 4.3.1.1. US
      • 4.3.1.2. Mexico
      • 4.3.1.3. Canada
    • 4.3.2. Europe
      • 4.3.2.1. France
      • 4.3.2.2. Italy
      • 4.3.2.3. Germany
      • 4.3.2.4. Spain
      • 4.3.2.5. Sweden
      • 4.3.2.6. Rest of Europe
    • 4.3.3. Asia-Pacific
      • 4.3.3.1. India
      • 4.3.3.2. China
      • 4.3.3.3. Japan
      • 4.3.3.4. Rest of Asia-Pacific
    • 4.3.4. Rest of the World

5. Competitive landscape

  • 5.1. Major players in the market
  • 5.2. mergers and acquisitions
  • 5.3. New product launches
  • 5.4. Agreement, Collaborations, and Partnerships
  • 5.5. Recommendations for New players in the market
  • 5.6. Recommendations for Existing players in the market

6. Company profiles

  • 6.1. Zoetis animal healthcare
    • 6.1.1. Financial Overview
    • 6.1.2. Business overview
    • 6.1.3. Business strategies
  • 6.2. Merck
    • 6.2.1. Financial Overview
    • 6.2.2. Business overview
    • 6.2.3. Business strategies
  • 6.3. Merial (Animal Health Division Of Sanofi)
    • 6.3.1. Financial Overview
    • 6.3.2. Business overview
    • 6.3.3. Business strategies
  • 6.4. Elanco
    • 6.4.1. Financial Overview
    • 6.4.2. Business overview
    • 6.4.3. Business strategies
  • 6.5. Bayer healthcare
    • 6.5.1. Financial Overview
    • 6.5.2. Business overview
    • 6.5.3. Business strategies
  • 6.6. Ceva Animal Health, Inc.
    • 6.6.1. Financial Overview
    • 6.6.2. Business overview
    • 6.6.3. Business strategies
  • 6.7. Virbac
    • 6.7.1. Financial Overview
    • 6.7.2. Business overview
    • 6.7.3. Business strategies
  • 6.8. Boehringer Ingelheim
    • 6.8.1. Financial Overview
    • 6.8.2. Business overview
    • 6.8.3. Business strategies

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Sources
  • 7.3. Bibliography
  • 7.4. Disclaimer
Back to Top